Henig Noreen
Insider CIK 1810995 · RNA Director · KZR Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 22,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 11,323 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 15,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 9,534 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 22,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 13,489 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 10,034 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 6,692 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 6,692 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 13,489 | — | $0 | 13,489 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 180,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 300,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 220,000 | — | $0 | 220,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 220,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 180,000 | — | $0 | 180,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 280,000 | — | $0 | 280,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | D To issuer deriv | 2023-07-24 | 2023-07-26 | 280,000 | — | $0 | 0 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-07-24 | 2023-07-26 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2023-01-08 | 2023-01-10 | 220,000 | — | $0 | 220,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2022-01-05 | 2022-01-07 | 180,000 | — | $0 | 180,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2021-06-16 | 2021-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2021-01-08 | 2021-01-11 | 280,000 | — | $0 | 280,000 | SEC↗ |
| KZR Kezar Life Sciences, Inc. | A Award deriv | 2020-05-01 | 2020-05-04 | 300,000 | — | $0 | 300,000 | SEC↗ |